Literature DB >> 11745758

A study of amorphous molecular dispersions of indomethacin and its sodium salt.

P Tong1, G Zografi.   

Abstract

Amorphous solid dispersions of indomethacin (IMC) and sodium indomethacin (NaIMC) over a range of compositions were prepared by physically mixing amorphous IMC and amorphous NaIMC, as well as by coprecipitation from methanol solution. Measurement of glass transition temperatures, T(g), for the physical mixtures revealed two values indicating, as expected, phase separation. In contrast, all samples of coprecipitated materials exhibited one value of T(g), which was greater than that predicted for ideal miscibility in the formation of a molecular dispersion. Such nonideality suggests a stronger acid-salt interaction in the amorphous state than that between acid-acid and salt-salt. FTIR spectroscopic analysis provides evidence for interactions between NaIMC and IMC through a combination of hydrogen bonding and ion-dipole interactions between the carboxylic group of the acid and the carboxylate anion of the salt. The inhibition of isothermal crystallization of IMC by NaIMC only when in molecular dispersion is believed to result from the interaction between the acid and the salt, which prevents the formation of hydrogen-bonded carboxylic acid dimers for IMC, required for the formation of crystal nuclei and crystallization. Copyright 2001 Wiley-Liss, Inc. and the American Pharmaceutical Association

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11745758     DOI: 10.1002/jps.1150

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  11 in total

1.  Microcalorimetric measurement of the interactions between water vapor and amorphous pharmaceutical solids.

Authors:  David Lechuga-Ballesteros; Aziz Bakri; Danforth P Miller
Journal:  Pharm Res       Date:  2003-02       Impact factor: 4.200

2.  Effect of Formulation and Process Parameters on the Disproportionation of Indomethacin Sodium in Buffered Lyophilized Formulations.

Authors:  Sampada Koranne; Seema Thakral; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2018-01-05       Impact factor: 4.200

3.  Effects of water vapor absorption on the physical and chemical stability of amorphous sodium indomethacin.

Authors:  Ping Tong; George Zografi
Journal:  AAPS PharmSciTech       Date:  2004-03-12       Impact factor: 3.246

4.  Cocrystal formation during cogrinding and storage is mediated by amorphous phase.

Authors:  Adivaraha Jayasankar; Anongnat Somwangthanaroj; Zezhi J Shao; Naír Rodríguez-Hornedo
Journal:  Pharm Res       Date:  2006-09-19       Impact factor: 4.200

5.  Amorphization of Indomethacin by Co-Grinding with Neusilin US2: amorphization kinetics, physical stability and mechanism.

Authors:  Deepak Bahl; Robin H Bogner
Journal:  Pharm Res       Date:  2006-08-23       Impact factor: 4.200

6.  The use of inverse phase gas chromatography to study the glass transition temperature of a powder surface.

Authors:  Graham Buckton; Ameet Ambarkhane; Kim Pincott
Journal:  Pharm Res       Date:  2004-09       Impact factor: 4.200

7.  Co-crystals: a novel approach to modify physicochemical properties of active pharmaceutical ingredients.

Authors:  A V Yadav; A S Shete; A P Dabke; P V Kulkarni; S S Sakhare
Journal:  Indian J Pharm Sci       Date:  2009-07       Impact factor: 0.975

8.  Amorphization alone does not account for the enhancement of solubility of drug co-ground with silicate: the case of indomethacin.

Authors:  Deepak Bahl; Robin H Bogner
Journal:  AAPS PharmSciTech       Date:  2008-01-19       Impact factor: 3.246

9.  Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters.

Authors:  Patrick J Marsac; Tonglei Li; Lynne S Taylor
Journal:  Pharm Res       Date:  2008-09-09       Impact factor: 4.200

10.  Drug-Polymer Solubility Determination: A New Thermodynamic Model Free from Lattice Theory Assumptions.

Authors:  Luis Almeida E Sousa; Kata J Dömötör; Mafalda Paiva; Constança Cacela
Journal:  Pharm Res       Date:  2019-11-01       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.